Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |